Lateral flow immunoassay for detection of HIV-1 and HIV-2 antibodies and p24 antigen. Provides comprehensive fourth-generation screening for HIV infection.
Manufactured by
Nanjing, Jiangsu, China
Jiangsu Medomics Medical Technology Co., Ltd., founded in October 2017, is located at Biotech and Pharmaceutical Valley of the National Jiangbei New Area, Nanjing, Jiangsu Province. It is an international high-tech enterprise driven by innovation in the area of medical devices R D, production and sales. Medomics focuses on diagnosis of microorganisms, tumors and some rare diseases, mainly engaged in the research and development, production and sales of in vitro diagnostic reagents and automatic instruments. Medomics owns two R D centers in China and the US, independent intellectual property rights of fluorescent staining technology, protein labeling technology, time-resolved immunofluorescence detection technology, image processing and analysis technology and other innovative technology platforms, as well as a total of more than 2,000 square meters of GMP purification production workshop that meets the product standards of FDA, CE and CFDA. Medomics also has a multidisciplinary expert team with abundant experience in the industry, including senior experts in immunology, microbiology, applied physics, polymer materials, medical imaging, optical systems, etc. The members of the technical team are led by doctors from many famous institutions, such as Osaka University, North Carolina University, University of Nebraska Lincoln, Zhejiang University, Sichuan University and other institutions. At the very beginning of COVID-19 on early 2020, Medomics developed IgM/IgG antibody detecting kit with the team of Zhong Nanshang. And Medomics published the first research paper on international journal together with State Key Laboratory of Respiratory Disease (National Clinical Research Center for Respiratory Disease, Guangzhou Institute of Respiratory Health). The detecting kit was validated by CDC, Harvard Medical School and Columbia University Irving Medical Center etc. Until May 2020, the kit has been exported to dozens of countries and areas, making great help against SARS-Cov-2. At present, Medomics s series products of SARS-Cov-2 detection have been developed according to ISO 13485 Quality System and European CE Certification.
✦ Product-Specific Coverage
Based on AI-matched alternatives related to this product across Suplivia's medical sourcing network.
Generated for this product
AI-matched supplier coverage based on related product alternatives.
HANGZHOU LAIHE BIOTECH CO.,LTD
China · 1 relevant product
Biopanda Reagents
United Kingdom · 4 relevant products
Coei Biotech
China · 1 relevant product
Beijing Jinwofu Bioengineering Technology Co.,Ltd.
China · 1 relevant product
Athenese-Dx Private Limited
India · 3 relevant products
Zybio Inc.
China · 1 relevant product
Hangzhou Frenovo Biotech Co., Ltd
China · 3 relevant products
Gaobeidian PRISES Biotechnology Co., Ltd
China · 1 relevant product
Atom Scientific Ltd
United Kingdom · 1 relevant product
Zhejiang Orient Gene Biotech Co.,Ltd.
China · 1 relevant product
60 more relevant manufacturers available
Get free access to all relevant manufacturers for this product.
See all manufacturers →5 more sourcing countries available
Get free access to all sourcing countries identified for this product.
See all countries →See the full supplier coverage for this product
Get free access to all relevant manufacturers, sourcing countries, and product alternatives.
✓ Free for medical industry professionals.
from other manufacturers
from other manufacturers
12 of 104 closest product alternatives
HANGZHOU LAIHE BIOTECH CO.,LTD · China
High-sensitivity, high-specificity competitive binding immunoassays built on Lateral Flow Immunoassay (LFIA) technology for clinical, workplace, and point-of-care drug screening. Validated against GC/MS laboratory standards to deliver accurate, reliable results with minimized false positives. Available in customizable multi-panels up to 14-in-1 with read times under 5 minutes and custom cut-off levels available for OEM customers.
Biopanda Reagents · United Kingdom
Lateral flow test for rapid detection of HIV p24 antigen, useful in early HIV infection detection during the window period. Enables earlier diagnosis than antibody-only tests.
Coei Biotech · China
Rapid HIV-1/2 antibody and p24 antigen combo immunochromatographic test kit using colloidal gold technology for point-of-care detection. Designed for serological screening and early-stage HIV diagnosis in clinical and laboratory settings. Detects both antibodies and p24 antigen in a single test, enabling simultaneous identification of acute and established infections.
Biopanda Reagents · United Kingdom
Lateral flow immunoassay for rapid detection of HIV-1 and HIV-2 antibodies in serum, plasma, or whole blood. Used for point-of-care and laboratory screening of HIV infection.
Beijing Jinwofu Bioengineering Technology Co.,Ltd. · China
A rapid diagnostic test kit for the detection of HIV antibodies to both HIV-1 and HIV-2. This test provides quick screening for HIV infection.
Athenese-Dx Private Limited · India
Fourth generation rapid test detecting both HIV antibodies and p24 antigen. Reduces window period and enables earlier detection of infection.
Zybio Inc. · China
Immunoassay for HIV-1/HIV-2 antibody detection in blood screening. High sensitivity and specificity for diagnostic confirmation.
Hangzhou Frenovo Biotech Co., Ltd · China
Rapid antigen detection test for HIV p24 protein. Identifies early HIV infection during the window period before antibody development.
Gaobeidian PRISES Biotechnology Co., Ltd · China
A fourth-generation rapid diagnostic test kit for simultaneous detection of HIV antibodies and antigens in blood samples for early HIV detection.
Atom Scientific Ltd · United Kingdom
Rapid and laboratory-based HIV antibody and antigen detection systems. Provides screening and confirmatory testing for HIV diagnosis.
Zhejiang Orient Gene Biotech Co.,Ltd. · China
Rapid immunological test for detection of HIV antibodies and antigens. Supports HIV screening in clinical and point-of-care settings.
J. Mitra & Co. Pvt. Ltd. · India
ELISA-based immunoassay for HIV antibody and antigen detection. Supports both screening and confirmatory testing for human immunodeficiency virus.
92 more product alternatives available
Create a free account to compare more product alternatives and supplier options.
© 2026 Suplivia · Home · Browse Products